Molecular subtyping of male breast cancer by immunohistochemistry. - Wikidata - wikimedia - TriplyDB

Molecular subtyping of male breast cancer by immunohistochemistry.

Molecular subtyping of male breast cancer by immunohistochemistry.

http://www.wikidata.org/entity/Q42496958

about

Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship The effect of antineoplastic drugs in a male spontaneous mammary tumor model Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer Treatment outcomes for male breast cancer: a single-centre retrospective case-control study.Immunophenotyping invasive breast cancer: paving the road for molecular imaging Prognostic value of automatically extracted nuclear morphometric features in whole slide images of male breast cancer.Male breast carcinoma: a clinicopathological and immunohistochemical characterization study.Differential expression of growth factor receptors and membrane-bound tumor markers for imaging in male and female breast cancer.Prognostic value of mitotic index and Bcl2 expression in male breast cancer.Triple negative breast cancers have a reduced expression of DNA repair genes Expression of connective tissue growth factor in male breast cancer: clinicopathologic correlations and prognostic value Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer.Obesity and male breast cancer: provocative parallels?Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer.Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.Prognostic models in male breast cancer.Male Breast Cancer Has Limited Effect on Survivor's Perceptions of Their Own Masculinity.Male Breast Carcinoma: A Clinical and Pathological Review.Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.The Genomic Landscape of Male Breast Cancers.The Management and Outcomes of Male Breast Cancer.Do columnar cell lesions exist in the male breast?Is there 'progression through grade' in ductal invasive breast cancer?Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.Immunophenotyping of male breast cancer.Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification.Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences.Protein biomarkers for subtyping breast cancer and implications for future research.Dietary Supplementation with Methylseleninic Acid Inhibits Mammary Tumorigenesis and Metastasis in Male MMTV-PyMT Mice.Tracing differences between male and female breast cancer: both diseases own a different biology.Fibrotic focus and hypoxia in male breast cancer.Chromosome 17 copy number changes in male breast cancer.Male breast cancer: finding the way in this uncommon path.Magnetic resonance imaging findings of high-grade ductal carcinoma in situ of the male breast: A case report.

P2860

Q27025244-0E3B40F0-9385-4A63-AB29-D6E46793E4A7 Q28533591-2E239036-0665-4F42-B6C3-ECEA10815D9B Q28729209-82375FA7-6326-49E7-8E95-0EDC0E5E5075 Q33763889-BECDA7C6-C727-44AC-A377-80616321840C Q34303266-80F2F5CD-8772-492F-9735-5B23C6834225 Q34382247-01B7A16F-E5F2-41A4-AC49-0DD1EDCC1B31 Q34501947-18D8F17A-A5D8-44C4-809D-D95125CFB670 Q34544957-B3F96F53-029D-4E37-935C-CFE2DB8A09B7 Q34661870-4A95CFA1-8875-4434-B4CB-528124A3F559 Q34794035-4F90DF05-2889-499D-B277-4B3CC3B4AF33 Q35148021-5E2E56DA-ADDF-41DC-BC5B-188246BE2BA3 Q35674829-15171C53-E8A8-4CE6-BEBD-3449BDF0AF90 Q35687528-3EADB487-9B0B-4E8D-A71F-99196D90599F Q36067806-6D42FB9F-C058-4E5A-BAE7-8E567E69AB9E Q36147178-35EBB2FD-739A-4230-B75E-84E5516FD07B Q36393217-3EEECCDF-F70E-4115-A92F-4A59EC66E8AB Q36544876-F87D5572-5D67-418C-9873-9AB45F3D226E Q36689124-F8849E7C-DF02-4228-AD07-B972E6A2DEF8 Q36924432-4A18E3F2-198E-4199-9F89-DB8A7BEFD8DA Q37341927-30264502-90E7-4945-9C5A-006A3371FFBD Q38728678-9087A57E-DEFF-4ED7-A66A-19FD19048BD3 Q39004442-D7772D81-D327-4247-9764-147A014BEBBB Q40556065-5647A76E-01CE-4B6F-988C-1008385EA5EB Q41739963-2FD0ACD7-71F1-42EE-903D-6BACC1788664 Q42204889-55BC32E4-C249-4A09-943E-ABF8BB51FB00 Q42449757-1A20ACA0-302E-433A-ADC6-AC1E19F3F5D5 Q42511105-B788C678-F7B4-454D-9E63-7512863CFAE4 Q42511496-1696F12A-BDB8-447D-AEAD-50270437699B Q42511904-63F51291-6434-4E52-BE45-93A940E8871E Q42516409-8ED82C7C-FF20-43F4-B2FC-8F7025251872 Q43891146-7DB4A1BA-CE2A-483F-B66C-9C46580D7712 Q45342178-7FB6DAE2-D38E-4063-AF13-F59C56B0BCD3 Q45851310-C8AF2EBE-656A-48F5-BD66-9C889BE6E570 Q47261659-70451CAA-08C0-4E18-937F-18ADDA1C452E Q47651896-E3926167-2A73-41F2-AAFE-143D4EC710DB Q50920420-49E00F81-CBC8-4FFA-B665-075357777A9A Q51333044-3722D498-BF61-476F-A97F-25FFEF184206 Q54165077-3D55D5CF-4CBA-4AEB-83AC-21C2D330B3DD Q54775458-D829BDAA-F2BB-4853-B2DE-D36B90337B0B Q55423893-18FA018E-83C7-4A4C-AEB5-16EA1C110B30

P2860

Molecular subtyping of male breast cancer by immunohistochemistry.

http://www.wikidata.org/entity/Q42496958

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Molecular subtyping of male breast cancer by immunohistochemistry.

@en

Molecular subtyping of male breast cancer by immunohistochemistry.

@nl

type

label

Molecular subtyping of male breast cancer by immunohistochemistry.

@en

Molecular subtyping of male breast cancer by immunohistochemistry.

@nl

prefLabel

Molecular subtyping of male breast cancer by immunohistochemistry.

@en

Molecular subtyping of male breast cancer by immunohistochemistry.

@nl

P1433

Q42496958-423C9D16-5C10-4F40-97C9-2BF1BB2E66D3

P1476

Q42496958-FAA84670-C18A-47E9-9C1F-64F118BE78F7

P2093

Q42496958-0706337D-54DB-40A5-9A2A-5ACE2A16B147

Q42496958-16CC2CCA-2599-4C94-86C4-1A8186E0BD31

Q42496958-5D035C78-A6A4-4F03-AA16-5DA97F2FA0CB

Q42496958-5E5B9442-BC49-47A4-AD2C-1C8C52770EBE

Q42496958-5FADE6FB-688D-469E-B8D6-B5BEC1EE06B9

Q42496958-7114D060-368B-4B96-881E-CCA6CC8C70D4

Q42496958-A162B7BA-3E9B-4D96-9B7D-CF0E9C377DF8

Q42496958-BCBD8D26-AA1A-44A3-AA60-488F942A97BB

Q42496958-E3E3F36F-7416-4B81-8CB0-6C1D9681A56F

P2860

Q42496958-0A0954D6-D7FB-4E75-A54A-B01549E34A69

Q42496958-0AA1A4BA-65E6-4402-B0E1-26D1AD379691

Q42496958-1E2FF0DB-A886-4703-9766-A896786B3FA7

Q42496958-28F81138-926B-437A-99EC-053C89C03743

Q42496958-2983B908-3341-4AF0-8716-93362A5DE831

Q42496958-30E2E924-0303-46C7-9D01-77DCF941CB38

Q42496958-33FB3088-F166-4632-A260-724CA72B76ED

Q42496958-357B9C3C-923A-4081-8F22-BF0F6E1DE292

Q42496958-46D8F8ED-1E53-48E0-AAD9-9D31531EEE66

Q42496958-4E2DA2BE-6C4E-419F-A4AA-E2DAD4BFCECC

P2888

Q42496958-77C8A170-AD92-4621-85C7-7297AEF8264B

P304

Q42496958-3BEBA024-C126-4074-AE24-0E531979A1AE

P31

Q42496958-7CD1127C-A6F1-425A-96C0-0303838A4D83

P356

Q42496958-5DBCC5FD-EBCB-4408-8B0E-151EB4D20210

P433

Q42496958-A2019662-4C61-466D-ABF3-FC7061A89605

P478

Q42496958-1CC93551-9915-4A65-860E-999C6A31DCC1

P577

Q42496958-7D0BD4FA-EF08-4F26-9DA3-67251ED57805

P5875

Q42496958-03C59411-F155-46CE-9559-8366F1965368

P6179

Q42496958-181584FA-C58A-44A4-BBCB-72099E7E7F66

P698

Q42496958-3B431FCD-BAD2-4B22-98F2-50310CEF9337

P921

Q42496958-17ED5052-5BC7-4CDD-9D47-2BA1DCD6CF37

P356

MODPATHOL.2011.174

P1433

Modern Pathology

P1476

Molecular subtyping of male breast cancer by immunohistochemistry.

@en

P2093

Anoek H J Verschuur-Maes

http://www.w3.org/2001/XMLSchema#string

Bernd Hinrichs

http://www.w3.org/2001/XMLSchema#string

Horst Buerger

http://www.w3.org/2001/XMLSchema#string

Joost J Oudejans

http://www.w3.org/2001/XMLSchema#string

Marieke C H Hogenes

http://www.w3.org/2001/XMLSchema#string

Paul J van Diest

http://www.w3.org/2001/XMLSchema#string

Peter C de Bruin

http://www.w3.org/2001/XMLSchema#string

Petra van der Groep

http://www.w3.org/2001/XMLSchema#string

Robert Kornegoor

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

Cancer statistics, 2010

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Breast carcinoma in men: a population-based study

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Male breast cancer: a population-based comparison with female breast cancer.

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.

P2888

modpathol.2011.174

P304

398-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2011.174

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51773423

http://www.w3.org/2001/XMLSchema#string

P6179

1038830677

http://www.w3.org/2001/XMLSchema#string

P698

22056953

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry